Humoral immune responses are tailored to the invading pathogen through regulation of key transcription factors and their networks. This is critical to establishing effective antibody-mediated responses, yet it is unknown how B cells integrate pathogeninduced signals to drive or suppress transcriptional programs specialized for each class of pathogen. Here, we detail the key role of the transcription factor c-Myb in regulating the T-bet-mediated anti-viral program. Deletion of c-Myb in mature B cells significantly increased serum IgG2c and CXCR3 expression by upregulating T-bet, normally suppressed during Th2-cell-mediated responses. Enhanced expression of T-bet resulted in aberrant plasma cell differentiation within the germinal center, mediated by CXCR3 expression. These findings identify a dual role for c-Myb in limiting inappropriate effector responses while coordinating plasma cell differentiation with germinal center egress. Identifying such intrinsic regulators of specialized antibody responses can assist in vaccine design and therapeutic intervention in B-cell-mediated immune disorders.
INTRODUCTION
The success of the immune system in protecting the host from a multitude of foreign pathogens is, in large part, due to its adaptability (Tarlinton and Good-Jacobson, 2013) . Fine-tuning cellular function according to the type of pathogen is central to the adaptive immune response. During a humoral immune response, this refinement is typified by modulation of the B cell antigen receptor (BCR) structure to generate protective antibodies of optimal affinity and immunoglobulin (Ig) isotype matched to the infecting pathogen. Dysregulation of these processes can result in serious B cell disorders, such as autoimmunity. Thus, this specific matching is essential to generate appropriate and effective targeting of antibody to clear bacterial, viral, or parasitic infection without damaging the host.
Germinal centers (GCs) are transient structures formed during humoral immune responses that enhance the quality of memory and plasma cell (PC) populations. Tailoring of BCR effector function and affinity is achieved by two mechanisms leading up to and within the GC: somatic hypermutation (SHM) and classswitch recombination (CSR). SHM of Ig V genes drives affinity maturation due to selective expansion of cells with improved antigen binding (Victora and Nussenzweig, 2012) . CSR exchanges the Ig heavy-chain constant region from that encoding IgM, expressed by naive B cells, to one of three isotypes with specialized effector functions: IgG, IgA, and IgE. IgG, comprising four subclasses, is important for clearing a wide range of infections. For instance, immunization of mice with soluble proteins induce mainly IgG1, whereas neutralizing antibodies to viruses are dominated by the IgG2a/c isotype (hereinafter referred to as IgG2c) (Coutelier et al., 1987) .
Different types of pathogens induce a unique cytokine milieu during an immune response, leading to the specialization of both Th and B cell responses (Crotty, 2011) . B cells integrate these extrinsic signals to produce the Ig effector phenotype optimized for each class of pathogen (Deenick et al., 2005; Stevens et al., 1988) . For example, interferon gamma (IFNg) promotes switching to IgG2c, whereas interleukin (IL)-4 promotes switching to IgG1 and IgE (Snapper and Paul, 1987) . B cells responding to a pathogen will promote one class of antibody response while suppressing other classes to ensure targeted responses and to avoid Ig-mediated immune disorders. Is it likely that intrinsic molecular programs mediate this balance to allow plasticity in the responding cells tailored to the immunogen. Cytokines can activate unique transcription factors that target the switching machinery in B cells to specific isotypes in a context-specific manner. In particular, B cell-intrinsic expression of T-bet has a central role in mediating an anti-viral B cell-specific program (Barnett et al., 2016; Rubtsova et al., 2013) . Specifically, T-bet induces IgG2c production downstream of IFNg signaling (Peng et al., 2002) and regulates survival of IgG2c memory B cells (Wang et al., 2012) and migration of PC to sites of inflammation via expression of CXCR3 (Moser et al., 2006) . Conversely, how such an anti-viral program is suppressed to permit altered dominance in responses to other pathogens is not clear.
Here, we describe a crucial role of the transcription factor c-Myb in repressing the T-bet-driven anti-viral B cell program. Furthermore, inappropriate expression of T-bet and CXCR3 resulted in the dysregulation of PC differentiation within the GC. Thus, c-Myb is key to controlling inherent B cell plasticity and establishing class-specific immune responses.
RESULTS

Dysregulation of GC-to-PC Progression in the Absence of c-Myb
We recently demonstrated that c-Myb is essential for the migration of PCs to the bone marrow (BM) to form long-lived immunity (Good-Jacobson et al., 2015) . c-Myb has also been shown to be expressed in human GC B cells (Basso et al., 2012) . While c-Myb is not required for GC formation after immunization with the model antigen (4-hydroxy-3-nitrophenyl)-acetyl conjugated to Keyhole Limpet Hemocyanin (NP-KLH) in alum, GCs declined earlier in B cell-specific c-Myb-deficient mice than in wild-type controls (Good-Jacobson et al., 2015) . In line with these data, a recent study demonstrated that Nur77 + IgG1 + GC B cells upregulated c-Myb in comparison to Nur77 -cells (Gitlin et al., 2016) . Together, these data suggest that c-Myb may regulate postselection processes within the GC. Differentiation into PCs involves downregulation of GC and B cell markers and the upregulation of PC markers, including CD138. In B cell-specific c-Myb-deficient mice (c-Myb f/f Cd23 Cre/+ ), a sub-population of GC B cells expressed CD138 while retaining GC B cell markers, hereinafter referred to as GC-PCs ( Figures 1A and 1B Figure 1E ), the latter being similar to the control chimera (C1 in Figure 1E ). These data demonstrate B cell-intrinsic dysregulation of GC-to-PC differentiation in the absence of c-Myb.
Affinity Maturation and Selection of CD138 + GC B Cells
A major outcome of a successful T-dependent immune response is the establishment of high-affinity PC and memory B cells. We, therefore, investigated V H mutations to assess affinity maturation of the BCR within the GC ( Figures 1F-1J and 1I). However, the representation of the affinity-enhancing W33L mutation was 30% in c-Myb f/f Cd23 Cre/+ mice, compared to >80% in controls ( Figure 1J ). In contrast, the proportion of GC B cell V H sequences with the W33L was similar between datasets ( Figure 1J ). These data confirm that the CD138 + GCphenotype cells are GC derived and suggest that, while affinity maturation of GC B cells was not affected by the absence of 
Regulation of a Transcriptional Program in GC B Cells by c-Myb
To understand the potential transcriptional changes being mediated by c-Myb, RNA sequencing (RNA-seq) was performed on sort-purified GC B cells, defined as CD138 neg CD95
hi CD38 lo (Figure 2A ; Table S1 ). In the absence of c-Myb, 1,150 genes were differentially expressed (p < 0.005), and 300 of these had at least a 2-fold change, with the majority of these genes upregulated in c-Myb-deficient GC B cells compared to wild-type.
Even though CD138 + cells were excluded during cell purification, PC genes were still upregulated in the absence of c-Myb (Figures 2A and 2B) . Prdm1 was upregulated 5-fold, while other PC regulators such as Irf4 and Xbp1 were increased to a lesser extent ( Figure 2B ), suggesting that c-Myb-deficient GC B cells, or at least a subset, were poised to differentiate.
We performed C2 canonical pathway analysis from the Molecular Signatures Database (Liberzon et al., 2011) and found that IFN signaling pathways were upregulated. This was surprising, considering that NP-KLH/alum immunization is a Th2-cell-mediated response, and thus, these pathways should largely be inactive. Consistent with the pathway analysis, however, c-Myb-deficient GC B cells upregulated Tbx21, the gene encoding T-bet. Furthermore, the T-bet-regulated genes Cxcr3 and Ighg2c were also upregulated ( Figure 2C ). T-bet expression in B cells has long been associated with IgG2c production (Peng et al., 2002) , and regulation of CXCR3 (Barnett et al., 2016; Serre et al., 2012) . However, a recent study demonstrated that the T-bet transcriptional program was important beyond mediating IgG2c production and was critical in the clearance of lymphocytic choriomeningitis virus (LCMV) (Barnett et al., 2016) . We compared our RNA-seq dataset with genes associated with T-bet expression in B cells, as assessed by T-bet-positive versus T-bet-negative isotype-switched B cells from LCMV-infected mice (Barnett et al., 2016) . Although some of the genes identified in the latter dataset may be the result of an unequal representation of GC B cells (e.g., Aicda, Fas, and Cd80), a number of genes were also differentially expressed in our dataset, such as Cxcr3, Tbx21 ( Figure 2C ), Cd80, Il2rb, Ctla4, and Tigit ( Figure 2D ).
Inappropriate Expression of T-bet Disrupts GC Selection and PC Differentiation RNA-seq analysis suggested that the T-bet-regulated gene expression program necessary for anti-viral responses was switched on in the absence of c-Myb. Accordingly, T-bet expression ( Figure 3A ) and NP-specific IgG2c serum antibody (Figure 3B) were increased in immunized c-Myb-deficient mice. Histological analyses confirmed an increase in IgG2c + ASCs in the spleens of immunized c-Myb-deficient mice ( Figures 3C  and 3D ). Lastly, CXCR3 expression was upregulated on c-Myb-deficient B220 lo CD138 hi cells ( Figure 3E ).
Together, the data thus far demonstrated that conditional deletion of c-Myb in B cells lead to an inappropriate T-bet-driven response. To confirm that this was directly downstream of the B cell-intrinsic loss of c-Myb, and not improper T cell priming such as increased IFNg production, we again utilized 50:50 mixed BM chimeras. Similar to intact mice, c-Myb-deficient GC B cells ( Figure 3F ) and plasmablasts (Figures 3G and 3H) in mixed BM chimeras expressed CXCR3, while wild-type cells within the same hosts did not, confirming that upregulation of T-bet-regulated genes was not due to a change in the microenvironment. Thus, c-Myb expression appeared to be critical in repressing a T-bet-regulated, anti-viral gene expression program during a Th2-cell-biased response. To confirm, we generated Tbx21
Cre/+ mice and immunized with NP-KLH in alum. As expected, deleting T-bet in c-Myb-deficient B cells ( Figure 3I ) restored both IgG2c ( Figure 3J ) and CXCR3 ( Figure 3K ) expression to wild-type levels. In contrast, it did not restore Table S1 . Cre/+ GC B cells disproportionately upregulated CD138, deleting T-bet within these mice reduced this population to near-normal frequency ( Figure 4A ) but did not correct GC B cell frequency ( Figure 4B) Figure S3B ) and, importantly, W33L representation ( Figure 4C ) equivalent to that in wild-type B cells (Figure 1J ; data shown for comparison). Thus, several of the GC B cell differentiation abnormalities arising from the loss of c-Myb were corrected by the removal of T-bet, providing a causal relationship.
In contrast to the Th2-cell-biased immunization model, T-bet expression is an important driver of B cell responses to viral infections (Barnett et al., 2016; Rubtsova et al., 2013 
Tbx21 f/f Cd23
Cre/+ mice ( Figure S3C-S3E ). Influenza-infected
c-Myb f/f Cd23
Cre/+ mice had a significantly increased representation of CD138 + GC cells compared to that in control mice in both the spleen and mediastinal lymph node, which again was corrected by the deletion of T-bet ( Figures 4D-4H) . Interestingly, the wild-type frequency of CD138 + GC B cells was increased at least 2-fold in flu-infected CD23-cre mice ( Figure 4F ), compared to NP-KLH in alum-immunized mice ( Figure 4A ). Together, these data demonstrate that c-Myb is an essential regulator of T-bet function, repressing the T-bet program during non-viral responses. Inappropriately lifting this repression resulted in premature differentiation of GC to PC in B cells responding to influenza.
Deleting CXCR3 Controls Aberrant GC-PC Population in c-Myb-Deficient Mice
Lastly, we asked which of a number of T-bet-regulated genes were inducing aberrant differentiation of GC B cells. Possible candidates included Blimp-1, Ig isotype switching, and CXCR3. While there have been conflicting reports of the relationship of T-bet with Blimp-1 (Cimmino et al., 2008; Xin et al., 2016) , induction of Blimp-1 was recently shown to be independent of T-bet (Xin et al., 2016) . Switching to secondary isotypes may induce PC differentiation, especially with respect to IgE (Yang et al., 2012) . Alternatively, aberrant upregulation of CXCR3 in GC B cells may disrupt the migratory program within the GC, resulting in altered localization and subsequent receipt of signals inducing premature differentiation of PC. To investigate, we generated novel mice in which CXCR3 was specifically deleted within B cells ( Figure S4 ). These mice were crossed with c-Myb-deficient mice, and the resultant animals were immunized with NP-KLH in alum.
Similar to 
Cd23
Cre/+ mice. However, it significantly reduced the frequency of CD138 + cells in the GC ( Figure 4K ). Thus, anomalous upregulation of T-bet and CXCR3 disrupted the ordered process of affinity maturation and PC differentiation within the GC, resulting in aberrant GC products. Together, these data demonstrate a role for c-Myb in ensuring regulated protective effects of molecular programs responsible for targeted B cell responses to distinct classes of pathogens.
DISCUSSION
A key element for a successful B cell response, and that of the vast majority of vaccines, is the ability to tailor the antibody structure to suit the pathogen. In mice and humans, the heavy chain of immunoglobulin has a number of variants with different effector attributes. Typically, one of these variants will dominate an immune response, although not to the exclusion of all others. Transcriptional programs that mediate other attributes such as migration and cytokine secretion also accompany antibody adaptation. How B cells are able to integrate potentially competing signals and then drive expression of one transcriptional program at the expense of another is not well understood. Here, we have revealed a mechanism by which c-Myb is required in B cells for effective responses to immunization with protein antigens by suppressing the T-bet-driven anti-viral response.
T-bet has essential roles in multiple immune lineages. In particular, T-bet is inextricably linked with the Th1/Th2 paradigm in the CD4 T cell lineage, working in opposition to GATA3 to determine Th1 and Th2 commitment, respectively. Our data suggest that the relationship between c-Myb and T-bet in B cells does not function in the same exclusive manner for IgG1-dominated responses. While c-Myb-deficient B cells have increased IgG2c antibody and PCs, they also maintain class switching to IgG1, a canonical Th2-cell-responsive pathway in mice. Thus, c-Myb may repress transcriptional networks appropriate in other immune contexts and, thus, focus the humoral response toward the outcome that provides the most potent immune protection. Further work is required to determine whether c-Myb only suppresses the T-bet-driven program or whether c-Myb is also able to regulate transcriptional networks associated with responses to other types of infections. The immune system balances protective mechanisms directed against foreign pathogens with aberrant immune responses that result in damage to the host. In the humoral system, diversity in antibody isotypes mediates the ability to clear diverse pathogens. However, immune disorders can also be mediated by particular isotypes, such as IgG2c and IgE. It is unknown how isotype switching is regulated appropriately (in response to pathogens) or inappropriately (in immune disorders). Dysregulated transcription factor expression has also been associated with immune disorders. Thus, regulatory mechanisms may resolve at two levels-normal transcriptional activation or repression during an immune response and regulation of aberrant expression. While the ability of T-bet to induce PC differentiation may be beneficial, it appears that, in the absence of c-Myb, this would be at the expense of appropriate selection of high-affinity PCs. The expression of c-Myb in the GC is targeted to Nur77 + GC cells (Gitlin et al., 2016) , suggesting that c-Myb has an important role in regulating the selectionmediated fate decisions of isotype-switched cells. As such, inappropriate expression of T-bet within GCs in c-Myb-deficient mice resulted in increased differentiation into PC, even during a response to influenza infection in which T-bet is normally expressed. In other cell types, the importance of T-bet in regulating immune responses does not simply rely on whether it is present or absent. In T cells, T-bet facilitates different fate decisions according to the level of expression (Joshi et al., 2007; Marshall et al., 2011) , thereby modulating effector or memory cell formation in accordance with the level of inflammatory mediators. The transcription factor Zeb2 has been reported to modulate differential T-bet function in CD8 T cells (Dominguez et al., 2015) , but it is unclear whether it is used in B cells. c-Myb can regulate transcriptional programs through the binding of co-factors such as p300 or by forming complexes with the H3K4me3 methyltransferase MLL1 and the protein Menin to regulate gene expression Nakata et al., 2010) . Thus, these transcriptional networks may be regulated at multiple levels by complex formation-through the recruitment of cofactors, inhibition of binding, and chromatin structure regulated by histone modifiers. Future work will investigate the chromatin landscape of these transcriptional networks in response to type I versus type II pathogens.
T-bet, CXCR3, and IgG2c have all been linked with B cells in disease. T-bet expression is an essential regulator of age-associated B cells, which accumulate in aged female mice, autoimmune-prone murine models, and elderly female autoimmune patients (Rubtsova et al., 2013 (Rubtsova et al., , 2017 . While it is clear that T-bet drives pathogenic autoantibody production, recent studies have shown contrasting roles for T-bet in autoimmune GC (Jackson et al., 2016; Rubtsova et al., 2017) . Further, in a chronic infection model, T-bet regulated B cell behavior and clearance of virus independent of antibody (Barnett et al., 2016) , suggesting context-driven roles for T-bet. Here, we demonstrate that inappropriate expression of CXCR3 due to T-bet dysregulation can impact on GC-to-PC differentiation. Although deletion of CXCR3 reduced the aberrant population of CD138 + GC B cells, it was not completely restored to wild-type frequency. T-bet and Bcl-6 have been noted to co-repress each other, and the upregulation of T-bet may repress Bcl-6, allowing for upregulation of Blimp-1. Accordingly, GC B cells had a decrease in Bcl-6 MFI while GC-PCs did not express Bcl-6 (data not shown). Therefore, it is likely that cumulative actions of T-bet, including CXCR3 expression, repression of Bcl-6, and increased isotype switching (Gitlin et al., 2016) , induce dysregulated GC B cell behavior when inappropriately expressed. Identifying the transcriptional mediators of T-bet activity will allow more targeted research into understanding the role of T-bet in B cell-mediated disease, as well as limiting aberrant production of IgG2c and PC migration to sites of immunopathology in autoimmune diseases.
Understanding the transcriptional networks regulating pathogen-specific B cell responses is essential in understanding how the balance between protection and immunopathogenesis is regulated in the immune system. Revealing these molecular relationships could potentially lead to therapeutic applications for rewiring cells away from deleterious isotypes. In sum, c-Myb brings the interplay between transcriptional regulation and cellular behavior together to regulate the critical balancing act that B cells play that allows pathogen clearance while constraining immune responses that can become damaging to the host.
EXPERIMENTAL PROCEDURES
Mice, Immunizations, and Purification of Cells Cd23-Cre (Kwon et al., 2008) mice were provided by M. Busslinger, and c-Myb fl/fl mice provided by J. Frampton (Emambokus et al., 2003) . Prdm1 gfp/+ reporter mice were generated as previously described (Kallies et al., 2004) . Tbx21 f/f mice were originally generated by S. Reiner (Wang et al., 2012) .
hCXCR3 conditionally deleted mice were generated as described in Figure S4 . Ly5.1 mice were maintained at Walter and Eliza Hall Institute (WEHI). Both males and females, over 7 weeks old, were used in this study. Animal procedures were approved by both WEHI and Monash University Animal Ethics Committees. Primary responses: mice were injected intraperitoneally with 100 mg NP conjugated to KLH (molar ratio between 13 and 20), precipitated on 10% alum. Influenza infections: mice were inoculated intranasally with 10 4 plaque-forming units (PFUs) of HKx31 (H3N2) influenza virus as previously described (Belz et al., 2000; Flynn et al., 1998) . Sort-purification: cells were stained with antibodies and purified by BD FACSAria or Influx (BD Biosciences), with purity >98%.
Flow Cytometry
Single cells were resuspended in PBS 2% FCS and stained for flow-cytometric analysis. Cells were analyzed on a BD FACSCanto or BD Fortessa (BD Biosciences), and data were analyzed with FlowJo software (Treestar). FcgRII/III (24G2; supernatant) was used to block non-specific binding. See Supplemental Experimental Procedures for antibody details.
BM Chimeras 50:50 chimeras: lethally irradiated Ly5.1 mice (2 3 550 rads) were reconstituted with 50% Ly5.1 BM and 50% c-Myb fl/fl Cd23 Cre/+ or Cd23 Cre/+ BM.
Mice were rested for 7-8 weeks and bled to test chimerism before NP-KLH in alum immunization.
Histology, ELISPOT, and ELISA Portions of spleens were frozen in optimal cutting temperature (OCT) compound (Tissue-Tek), and 7-mM sections were cut using a microtome (Leica) and stained for immunohistochemistry, as detailed previously (Zotos et al., 2010) . For immunofluorescence staining, portions of spleens were fixed in 4% paraformaldehyde and infiltrated with 30% sucrose before being embedded in OCT compound. Images were acquired on an LSM780 confocal microscope on an Axiovert 200M base (Carl Zeiss MicroImaging). Objective: 203 Plan Apochromat; NA = 0.8. Detectors are 23 PMT (photomultiplier tube) and a 32-channel GaAsP (gallium arsenide phosphide) array detector. The acquisition software used was Zen Black 2012. Images were analyzed with ImageJ (NIH). ASCs and antibody were analyzed by ELISPOT and ELISA, respectively, as previously described (Zotos et al., 2010) .
V H Sequencing
Individual cells were sort-purified on a BD FACSAria equipped with a plate sorter and sequenced as previously detailed (Zotos et al., 2010 
Statistical Analysis
Statistical analyses were performed using GraphPad Prism software, and statistical tests are stated in the figure legends. Means ± SEM are shown.
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